Fat, Metabolism and Obesity

Scientific Programme, ePosters & Abstracts

Previous issue | Volume 94 | ESPE2021 | Next issue

59th Annual ESPE (ESPE 2021 Online)

Online,
22 Sept 2021 - 26 Sept 2021

The 59th ESPE Annual Meeting will now be held online in September 2021.

Free Communications

Previous section
Adrenal

Table of contents

Next section
Growth Disorders

hrp0094fc2.1 | Fat, Metabolism and Obesity

Efficacy and Safety Results of a Phase 2 Trial of Setmelanotide in Obesity Due to SH2B1 Variants and 16p11.2 Deletion Syndrome

hrp0094fc2.2 | Fat, Metabolism and Obesity

Phase 3 Trial of Setmelanotide in Participants With Bardet-Biedl Syndrome: Placebo-Controlled Results

hrp0094fc2.3 | Fat, Metabolism and Obesity

A Phase 2 Trial of the Melanocortin-4 Receptor Agonist Setmelanotide in Obesity Due to SRC1 Insufficiency: Body Weight, Body Mass Index Z Score, and Safety Results

hrp0094fc2.4 | Fat, Metabolism and Obesity

PTEN germline mutations lead to adipose tissue overgrowth mediated via FOXO1 and SREBP1.

hrp0094fc2.5 | Fat, Metabolism and Obesity

Reference values for longitudinal body composition in children aged 0-5 years, using Dual-energy X-ray (DXA) absorptiometry

hrp0094fc2.6 | Fat, Metabolism and Obesity

Association between MRI Evidence of Hypothalamic Gliosis and Pubertal Development in Girls with Obesity

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more

ESPE Abstracts